with idiopathic complete isolated GHD (peak GH on provocative stimuli below 4 ng/ml, otherwise normal pituitary function), group 2 3 pts (2m, If, age 6-14yrs, height -1.8 to 2.2 SD) with idiopathic partial isolated GHD (peak GH above 4 and below 7 ng/ml), group 3 2 girls (age 2 and 17 yrs, height -2.0 and -3.1 SD) with idiopathic panhypopituitarism, and group 4 8 pts (6m, 2f, age 7-12yrs, height -2.6 ?I 0.9 SD) with acquired hypopituitarism: 4 with isolated hypopituitarism (3 post-radiation, 1 craniopharyngioma), 4 with panhypopituitarism (2 craniopharyngioma, 1 glioma, 1 histiocytosis X). wnsity in the intrasellar area on CT corresponded to that of cerebrospinal fluid in 12 of 18 pts (group l), 0/3 (group 2), 1/2 (group 3), and 2/8 (group 4, both postradiation). The overall incidence of PESS in the GID pts studied was thus over 48% while in children without endocrine dysfunction, it was only 5/213. It is concluded that PESS is more frequent than was assumed until now and that is most frequently associated with GHD.
Pediah-ics, Endocrine Unit,Dept. of Nanoradiolw.University of Milan, Italy.
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To search for the presence of mrplrstructural atoonmlities of the hypthalans TRANSIENT GROWTH HORMONE DEFICIENCY DURING BROMOCRYP-TINE TREATMENT FOR HYPERPROLACTINEMIA Growth hormone (GH) deficiency has been demonstrated in several patients with prolactinoma. Very often it was attrituted to tumor expansion and found to be permanent after surgery. In a 14-year-old boy with galactorrhea, arrested puberty (testesvolume 4ml) and poor growth (3cmIyear) elevated prolactin (PRL) levels (5800 mull) were found. MR imaging showed no abnormalities of the pituary gland. Nighttime sampling revealed persistent PRL elevation and low CH peaks (max. 12 mull). GH response to insuline induced hypoglycemia was also low (max. 10 mUl1) but GH increased normally after GRF injection (38 mull). Basal and stimulated LH and FSH values were prepubertal. 3 h. after the administration of 10 mg bromocryptine (B) PRL dropped to normal values and GH increased to 22 mull. After six months of treatment with B, height velocity doubled and normalization of GH secretion was observed. Basal LH, FSH and testosterone values remained prepubertal. In conclusion, GH deficiency in hyperprolactinemia can be restored during B treatment. The acute GH response to B may be predictive of the subsequent normalization of GH secretion during long term treatment. In isolated hyperprolactinernia a central dopaminergie defect is probably responsible for this deficient Onc hundred Iorty nine children and adolescents with growth hormone (hGII) deficiency were reviewed rctrospcctivcly in rclation to plasma basal and TRll stimulated prolactin (Prl) Levcl before and during long-term hcll thcrapy. The Collowing groups wer distinguished: Cr. 1 -TGHD (nz62, 41M, 21F); Cr. TI -MPIID (n=6i 44M, 18F); Gr. TI1 -Intra-or suprascllar tumors (n.25, 17M, 8F) lligh basal Prl ( 7 20 ngldl) were found in 6 IGIID patients (9.7%: During hcll therapy Prl normalized in all six. Ninetecn (30.7%) MPllD pnticnrs had high basal Prl. Following L-T4 therapy Prl normalizcd in 14 of them. All MPllD patients with high basal Prl had higher than normal TSll response to T R H High basal Prl levcls we, unrclatcd to stress and E2 thcrnpy. It is assumed that in some hypopituitary patients hCll deficiency is due to hypoactivity of thc cntccholaminergic tone leading to GII-RH deficicncy and high Prl Icvcls. This is reversed by hGll therapy. A low response of PI was found in 10 IGllD and 10 (16.1%) MPllD paticnts. A pituitary lesion was proven in these patients by a low response of CH to CII-RII and TSH to TRH. It thus secms that some ICIID paticnts arL actually MPllD being deficient in both hCH and Prl. In the tumor paticnts, 2 had high Prl preoparativcly. Post-op 5 had a low Prl rcsponsc to TRH indicating complete~hypophyscctomy and 6 develop< high Prl levels indicating hypothaljmic or stalk injury. It is concluded that dynamics oC hPrl sccretion should be investigated in all hypopituitary paticnts, including ICIID.
